Jazz Pharmaceuticals

Irish tax-registered pharmaceutical corporation

JAZZ Nasdaq ISIN IE00B4Q5ZN47 SEC CIK 1232524
Follow Jazz Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.2B +10.4% vs same quarter last year
Net income −$483.4M −292.3% vs same quarter last year
EPS, diluted −$7.48 −283.3% vs same quarter last year
Operating cash flow $506.1M +6.6% vs same quarter last year
Revenue by quarter
$1.1B
$897.8M
$1B
$1.1B
$1.2B
$1.1B
$1.2B
$1.2B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$2B$0$2B$4B$6BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.3B−$356.1M
FY24$4.1B$560.1M
FY23$3.8B$414.8M
FY22$3.7B−$224.1M
FY21$3.1B−$329.7M
FY20$2.4B$238.6M
FY19$2.2B$523.4M
FY18$1.9B$447.1M
FY17$1.6B$487.8M
FY16$1.5B$396.8M
FY15$1.3B$329.5M
FY14$1.2B$58.4M
FY13$872.4M$216.3M
FY12$586M$288.6M
FY11$272.3M$125M
MarginsShare of revenue
  • Operating margin
  • Net margin
−20%0%20%40%60%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−10.1%−8.3%
FY2417.6%13.8%
FY2315.1%10.8%
FY22−1.8%−6.1%
FY215.5%−10.7%
FY2016%10.1%
FY1924.6%24.2%
FY1832.5%23.6%
FY1732.7%30.1%
FY1639.8%26.7%
FY1538.4%24.9%
FY1416.7%5%
FY1339%24.8%
FY1233.8%49.2%
FY1146.9%45.9%
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.3B
FY24$1.4B
FY23$1.1B
FY22$1.2B
FY21$750.9M
FY20$884.6M
FY19$736.3M
FY18$778.5M
FY17$664.1M
FY16$582.7M
FY15$496M
FY14$371.3M
FY13$278.5M
FY12$243.8M
FY11$150.3M
Returned to shareholdersDividends paid and shares bought back
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$125M
FY24$311.4M
FY23$269.8M
FY22$54K
FY21$0
FY20$146.5M
FY19$301.5M
FY18$523.7M
FY17$98.8M
FY16$278.3M
FY15$61.6M
FY14$42.2M
FY13$136.5M
FY12$0
FY11$0
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Jazz Pharmaceuticals
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearJazz PharmaceuticalsHealthcare median
FY25−8.3%−30.6%
FY2413.8%−47%
FY2310.8%−58%
FY22−6.1%−80.4%
FY21−10.7%−71.9%
FY2010.1%−62.2%
FY1924.2%−46.3%
FY1823.6%−49.6%
FY1730.1%−45.9%
FY1626.7%−36%
FY1524.9%−38.4%
FY145%−35.5%
FY1324.8%−37.1%
FY1249.2%−29.1%
FY1145.9%−27.9%